Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Market Cap	9.21B
Revenue (ttm)	2.93B
Net Income (ttm)	152.23M
Shares Out	343.93M
EPS (ttm)	0.44
PE Ratio	60.90
Forward PE	33.49
Dividend	0.05 (0.18%)
Ex-Dividend Date	Jun 6, 2025

Volume	5,050,180
Average Volume	6,547,288
Open	27.09
Previous Close	26.79
Day's Range	26.47 - 27.66
52-Week Range	13.55 - 31.20
Beta	0.59
RSI	48.19
Earnings Date	Aug 23, 2025

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 4,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300702

Financial Performance

In 2024, SHE:300702's revenue was 2.63 billion, an increase of 4.10% compared to the previous year's 2.53 billion. Earnings were 55.94 million, an increase of 104.45%.